𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

✍ Scribed by Cummings, J; Raynaud, F; Jones, L; Sugar, R; Dive, C

Book ID
110000693
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
232 KB
Volume
103
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The development of composite circulating
The development of composite circulating biomarker models for use in anticancer drug clinical development
✍ Lee J. Lancashire; Darren L. Roberts; Caroline Dive; Andrew G. Renehan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulin‐

Fit-for-purpose in veterinary drug resid
Fit-for-purpose in veterinary drug residue analysis: Development and validation of an LC-MS/MS method for the screening of thirty illicit drugs in bovine urine
✍ Marta Leporati; Pierluigi Capra; Paola Brizio; Valentina Ciccotelli; Maria Cesar πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 407 KB πŸ‘ 1 views

## Abstract A selective and sensitive method for screening 31 analytes (nine corticosteroids, eight β‐agonists, seven anabolic steroids, six promazines and zeranol) in bovine urine was validated according to 2002/657/EC guidelines. Upon optimization of sample treatment conditions, the extraction wa